StonvexLoading…
StonvexStonvexStonvexCore line items from BLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.55B | $1.45B | $5.41B | $3.92B | $2.53B |
Operating Income | Not available | $175.04M | $791.93M | $612.29M | $397.28M |
Net Income | Not available | $104.81M | $521.73M | $417.21M | $151.60M |
EPS (Diluted) | $4.82 | $3.73 | $18.28 | $14.56 | $9.53 |
Total Assets | Not available | $6.71B | $6.61B | $6.41B | $5.12B |
Total Liabilities | Not available | $4.31B | $4.29B | $4.19B | $2.98B |
Cash & Equivalents | Not available | $268.85M | $184.74M | $1.14B | $842.49M |
Free Cash Flow OCF − CapEx | Not available | $146.74M | $696.89M | $537.52M | $321.36M |
Shares Outstanding | Not available | 28.14M | 28.07M | 28.11M | 28.26M |